Hidradenitis Suppurativa: Absence of Hyperhidrosis but Presence of a Proinflammatory Signature in Patients' Sweat.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
18 Oct 2022
Historique:
pubmed: 30 9 2022
medline: 20 10 2022
entrez: 29 9 2022
Statut: epublish

Résumé

The role of sweat glands in hidradenitis suppurativa has been largely neglected, despite the fact that its original designation, as "hidrosadénite phlegmoneuse", implied an inflammatory malfunction of the apocrine sweat glands as the underlying pathogenic driver. The aim of this study was to evaluate the role of apocrine sweat glands with respect to the proinflammatory environment of hidradenitis suppurativa. Therefore, gravimetric assessment and multiplex cytokine assays from sweat obtained from patients with hidradenitis suppurativa along with immunofluorescence cytokine/chemokine analysis of lesional apocrine glands- bearing hidradenitis suppurativa skin were performed. Gravimetric assessment of 17 patients with hidradenitis suppurativa revealed that the condition is not associated with hyperhidrosis. However, patients seem to be more affected by subjective sweating. The current data identified a complex proinflammatory signature in hidradenitis suppurativa sweat characterized by a significant upregulation of monocyte chemoattractant protein-1, interleukin-8 (CXCL8), and interferon-γ. In agreement with this, a strong in situ expression of these mediators could be observed in apocrine glands of lesional hidradenitis suppurativa skin. These data shed new light on the proinflammatory capacity of apocrine sweat glands in hidradenitis suppurativa, which may lead to reconsideration of the role of sweat glands in hidradenitis suppurativa pathology.

Identifiants

pubmed: 36172698
doi: 10.2340/actadv.v102.2731
pmc: PMC9677269
doi:

Substances chimiques

Chemokine CCL2 0
Interleukin-8 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00793

Références

Am J Pathol. 2013 Jan;182(1):163-71
pubmed: 23159944
J Am Acad Dermatol. 2020 Mar;82(3):753-754
pubmed: 31449904
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
PLoS One. 2013 Jul 11;8(7):e67666
pubmed: 23874436
J Invest Dermatol. 2016 Sep;136(9):1768-1780
pubmed: 27206704
J Eur Acad Dermatol Venereol. 2020 Apr;34(4):846-861
pubmed: 31838778
J Leukoc Biol. 2002 Nov;72(5):847-55
pubmed: 12429706
Br J Dermatol. 2012 May;166(5):1023-34
pubmed: 22136668
Front Immunol. 2019 Aug 09;10:1917
pubmed: 31447864
Allergol Int. 2018 Oct;67(4):455-459
pubmed: 30082151
Arch Dermatol. 2002 Apr;138(4):539-41
pubmed: 11939828
PLoS One. 2019 May 6;14(5):e0216249
pubmed: 31059533
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):462-471
pubmed: 34724272
Semin Cutan Med Surg. 2017 Jun;36(2):47-54
pubmed: 28538743
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2488-2498
pubmed: 35881108
Eur J Dermatol. 2019 Jun 1;29(3):294-301
pubmed: 31145081
Lab Invest. 2011 Aug;91(8):1188-94
pubmed: 21555999
J Am Acad Dermatol. 1998 Jan;38(1):1-17; quiz 18-20
pubmed: 9448199
J Biol Chem. 2004 Oct 1;279(40):41679-85
pubmed: 15284232
Dermatol Ther. 2019 May;32(3):e12841
pubmed: 30693648
Clin Exp Dermatol. 2017 Apr;42(3):261-265
pubmed: 28194809
Br J Dermatol. 2010 Jun;162(6):1261-8
pubmed: 20184581
Am J Clin Dermatol. 2020 Oct;21(5):741-748
pubmed: 32761500
Br J Dermatol. 2020 Dec;183(6):999-1010
pubmed: 33048349
Exp Dermatol. 2018 Feb;27(2):172-177
pubmed: 29222824
BMJ Case Rep. 2019 Jan 20;12(1):
pubmed: 30665927
J Am Acad Dermatol. 2010 Apr;62(4):706-8, 708.e1
pubmed: 20227585
Dermatol Monatsschr. 1986;172(10):585-8
pubmed: 3803659
Dermatol Surg. 2007 Aug;33(8):908-23
pubmed: 17661933
Acta Derm Venereol. 2018 Feb 7;98(2):191-194
pubmed: 28971209
J Leukoc Biol. 2004 Feb;75(2):163-89
pubmed: 14525967

Auteurs

Verena G Frings (VG)

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, DE-97080 Würzburg, Germany. frings_v@ukw.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH